So far, a number of mechanisms underlying PD-L1 regulation in cancer have been uncovered, including gene copy number variation [27, 28], oncogenic signaling [29–31], exosomal transfer [32, 33], and microRNAs at posttranscriptional level [34, 35]. Here, CD274 is linked to cancer.